Sector dividends Charles River Laboratories International, Inc. CBOE
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
CBOE
22:59:50 12/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 302.27 USD | +0.10% |
|
+3.99% | +51.24% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.45% | 1.59% | 20.5x | 4.83x | 7.33x | 14.72x | 16.66x | 70.61B | ||
| 0.05% | 0.1% | 27.46x | 5.25x | 7.51x | 23.56x | 23.96x | 51.01B | ||
| 0.97% | 1.12% | 33.37x | 4.48x | 6x | 17.96x | 25.15x | 48.1B | ||
| -.--% | -.--% | 33.47x | 6.22x | 3.25x | 14.03x | 20.7x | 42.78B | ||
| -.--% | -.--% | -19.64x | 20.57x | 203.45x | -20.92x | -19.93x | 40.67B | ||
| -.--% | -.--% | 46.95x | 7.58x | 5.34x | 29.33x | 33.69x | 40.3B | ||
| 0.42% | 0.43% | 27.18x | 2.18x | 7.73x | 20.09x | 23.49x | 30.59B | ||
| -.--% | -.--% | 32.53x | 3.41x | 6.94x | 18.03x | 21.62x | 28.16B | ||
| -.--% | -.--% | -14.69x | 1.24x | 5.97x | -7.21x | -5.73x | 24.36B | ||
| -.--% | -.--% | -60.75x | 32.31x | 11.86x | -60.25x | -67.7x | 21.97B | ||
| -.--% | -.--% | 30.05x | 3.58x | 5.6x | 18.75x | 21.19x | 21.89B | ||
| -.--% | -.--% | 34.8x | 25.94x | 5.72x | 25.98x | 27.18x | 17.08B | ||
| 0.33% | 0.2% | 44.22x | 10.83x | 16.41x | 33.73x | 36.24x | 15.49B | ||
| 1.04% | 1.18% | 25.71x | 2.83x | 2.23x | 9.6x | 14.86x | 14.99B | ||
| -.--% | -.--% | 18.52x | 5.7x | 5.52x | 12.91x | 13.67x | 14.83B | ||
| -.--% | -.--% | 73.13x | 4.68x | 4.21x | 16.18x | 20.08x | 14.41B | ||
| -.--% | -.--% | -15.24x | 52.54x | 3461.77x | -17.74x | -15.1x | 14.07B | ||
| -.--% | -.--% | 967.07x | 15.69x | 33.64x | 581.04x | -217.65x | 13.54B | ||
| Average | 0.24% | 0.26% | 72.48x | 11.66x | 211.14x | 40.55x | -1.54x | 29.16B | |
| Weighted average by Cap. | 0.35% | 0.39% | 44.90x | 9.47x | 115.20x | 25.20x | 7.21x |
Select your edition
All financial news and data tailored to specific country editions
















